Experimental drug telaglenastat aims to lower lung blood pressure
Disease control
Not yet recruiting
This study tests whether the drug telaglenastat, taken twice daily for 12 weeks, can safely lower blood pressure in the lungs and improve heart and lung function in adults with pulmonary hypertension. About 28 participants will receive the drug on top of their usual care. The mai…
Phase: PHASE1, PHASE2 • Sponsor: Chan, Stephen, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC